Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Earnings Scheduled For October 2, 2025

Author: Benzinga Insights | October 02, 2025 04:32am

• AngioDynamics (NASDAQ:ANGO) is projected to report quarterly loss at $0.13 per share on revenue of $72.53 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ANGO